Literature DB >> 7744814

Pax3 inhibits myogenic differentiation of cultured myoblast cells.

J A Epstein1, P Lam, L Jepeal, R L Maas, D N Shapiro.   

Abstract

Pax3 is an evolutionarily conserved transcription factor expressed in the lateral dermomyotome, a region that gives rise to limb muscle progenitors. Mutations in Pax-3 account for the mouse mutant Splotch which develops without limb musculature. We demonstrate that Pax3 can inhibit myogenic differentiation of C2C12 myoblasts normally induced by exposure to low serum. Specific missense mutations that affect the DNA binding characteristics of the two distinct DNA binding domains of Pax3 abolish this effect. Furthermore, we show that Pax3 can inhibit myogenic differentiation of 10T1/2 fibroblasts transfected with MyoD, but not of 10T1/2 cells transfected with myogenin. This anti-myogenic property is shared by a PAX3-forkhead fusion protein resulting from a t(2;13) chromosomal translocation found in pediatric alveolar rhabdomyosarcomas. These results suggest that Pax3 may suppress the terminal differentiation of migrating limb myoblasts and that the PAX3-forkhead fusion may contribute to the phenotype of alveolar rhabdomyosarcoma by preventing terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744814     DOI: 10.1074/jbc.270.20.11719

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma.

Authors:  R J Davis; F G Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Xenopus staufen2 is required for anterior endodermal organ formation.

Authors:  Cassandra K Bilogan; Marko E Horb
Journal:  Genesis       Date:  2012-02-17       Impact factor: 2.487

3.  AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.

Authors:  Mathivanan Jothi; Kochi Nishijo; Charles Keller; Asoke K Mal
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

4.  Pax3 induces differentiation of juvenile skeletal muscle stem cells without transcriptional upregulation of canonical myogenic regulatory factors.

Authors:  Arthur P Young; Amy J Wagers
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

5.  The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.

Authors:  Patrick J Miller; Andrew D Hollenbach
Journal:  Biochim Biophys Acta       Date:  2007-07-13

6.  Comparative analysis of paired- and homeodomain-specific roles in PAX3-FKHR oncogenesis.

Authors:  Youbin Zhang; Joel Schwartz; Chiayeng Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-12-01

7.  HDAC1 and HDAC2 control the specification of neural crest cells into peripheral glia.

Authors:  Claire Jacob; Pirmin Lötscher; Stefanie Engler; Arianna Baggiolini; Sandra Varum Tavares; Valérie Brügger; Nessy John; Stine Büchmann-Møller; Paige L Snider; Simon J Conway; Teppei Yamaguchi; Patrick Matthias; Lukas Sommer; Ned Mantei; Ueli Suter
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 8.  PAX3-FOXO1 fusion gene in rhabdomyosarcoma.

Authors:  Corinne M Linardic
Journal:  Cancer Lett       Date:  2008-05-23       Impact factor: 8.679

Review 9.  Gene expression networks: competing mRNA decay pathways in mammalian cells.

Authors:  Lynne E Maquat; Chenguang Gong
Journal:  Biochem Soc Trans       Date:  2009-12       Impact factor: 5.407

10.  Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation.

Authors:  Kevin N Dietz; Patrick J Miller; Andrew D Hollenbach
Journal:  Biochemistry       Date:  2009-12-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.